✦ LIBER ✦

Beyond Acid Suppression: New Pharmacologic Approaches for Treatment of GERD

✍ Scribed by Paul Kuo; Richard H. Holloway

Book ID: 107538561
Publisher: Springer
Year: 2010
Tongue: English
Weight: 130 KB
Volume: 12
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-010-0102-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New pharmacologic approaches for the per

New pharmacologic approaches for the perioperative treatment of ischemic cardiogenic shock

✍ Andreas Lehmann; Joachim Boldt 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 444 KB

M1885 Gastric Acid Suppression of a New

M1885 Gastric Acid Suppression of a New Oral Powder Omeprazole Suspension for Infants with GERD. Pilot Study

✍ Orsi, Marina; Donato, Gabriela; Busoni, Veronica; Arenoso, Hector J.; Soutric, J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Pharmacological approaches for the disco

Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis

✍ Michael W. Konstan; Pamela B. Davis 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 217 KB

S1069 New Approach to the Treatment of L

S1069 New Approach to the Treatment of Laryngopharyngeal Reflux Symptoms Using Rikkunshito (Japanese Herbal Medicine TJ-43) in Patients Who Responded Poorly to Acid Suppression Therapy

✍ Nobuhiko Oridate; Hiroshi Takeda; Yasushi Mesuda; Noriko Nishizawa; Masahiro Asa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Pharmacological inhibition of fatty acid

Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation

✍ Javier A. Menendez; Inderjit Mehmi; Vishal A. Verma; Poh K. Teng; Ruth Lupu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

## Abstract We designed our experiments to evaluate whether fatty acid synthase (FAS), a lipogenic enzyme linked to tumor virulence in population studies of human cancer, is necessary for the malignant transformation induced by Her‐2/neu (erbB‐2) oncogene, which is overexpressed not only in invasiv

G.P.11.05 The pharmacological chaperone

G.P.11.05 The pharmacological chaperone AT2220 increases trafficking, processing, and cellular activity of acid α-glucosidase and is a potential new treatment for Pompe disease

✍ A.C. Powe; J.F. Flanagan; R. Khanna; X. Wu; W. Liang; R. Dhulipala; T. Yin; K. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB